Suche starten De menü ClientConnect
Suche starten
Ergebnisse
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20160727
    Veröffentlichungsdatum: 5 September 2017

    Projektträger – zwischengeschaltetes Finanzinstitut

    HUVEPHARMA INTERNATIONAL BV

    Ort

    Beschreibung

    The project consists of the construction of new manufacturing facilities, as well as financing of the promoter's research, development and innovation (RDI) activities.

    Ziele

    The EIB loan will be supporting the capacity expansion of a mid-cap company in Bulgaria.

    Sektor(en)

    • Industrie - Verarbeitendes Gewerbe/Herstellung von Waren

    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 125 million

    Gesamtkosten (voraussichtlicher Betrag)

    EUR 212 million

    Umweltaspekte

    The project falls under Annex II of EIA Directive 2011/92/EU (implementation of an industrial facility for the production of pharmaceutical products). Full environmental details will be assessed during the appraisal.

    Auftragsvergabe

    The promoter is a private company not operating in the utilities sector and is thus not covered by EU directives on procurement.

    Projektstatus

    Unterzeichnet - 22/12/2017

    Haftungsausschluss

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Tags

    Bulgarien Industrie